Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non–muscle-invasive Bladder Cancer

Jennifer Linehan, Piyush K. Agarwal, Xianne Penny, Max Kates, Joseph Jacob, Seth P. Lerner, Rhonda C. Kines, John T. Schiller, Elisabet de los Pinos, Neal D. Shore, Jill Hopkins, Joseph McQuaid, Sabine D. Brookman-May · 2026

Read Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non–muscle-invasive Bladder Cancer by Jennifer Linehan, Piyush K. Agarwal, Xianne Penny, Max Kates, Joseph Jacob, Seth P. Lerner, Rhonda C. Kines, John T. Schiller, Elisabet de los Pinos, Neal D. Shore, Jill Hopkins, Joseph McQuaid, Sabine D. Brookman-May (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13279200.txt.

Description

Jennifer Linehan and colleagues report a 2026 early trial of a bladder cancer drug called bel-sar. The cancer is non muscle invasive bladder cancer, meaning it has not grown in the bladder wall muscle. Patients had mid or high risk disease. Current bladder drugs face high return rates and heavy repeat care, so new options are sought.

Bel-sar was given at set spots in the bladder and proved workable and well tolerated. Early signs showed tumour shrinkage, even at spots that got no direct dose. Blood and tissue checks showed strong immune wake up, with new immune clusters and immune memory in tissue. The dual action, direct cell kill plus immune drive, hints at lasting control with less repeat care, though larger trials must test that hope.

Catalog record

CREATORJennifer Linehan, Piyush K. Agarwal, Xianne Penny, Max Kates, Joseph Jacob, Seth P. Lerner, Rhonda C. Kines, John T. Schiller, Elisabet de los Pinos, Neal D. Shore, Jill Hopkins, Joseph McQuaid, Sabine D. Brookman-May
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47666
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13279200

Browse the full library · About the Tower of Babel